REPROTOX BIOTECH, LLC
Biotech · Private
Human testicular cell co-culture model for in vitro reproductive toxicity screening of industrial chemicals
- Grants
- $1.9M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Innovative three-dimensional testicular Co-culture (Mini-Testis) model for reproductive toxicity testing: a pathway based High throughput (HT) and High Content Analysis (HCA) | $202,115 | |
| Federal grant | Department of Health and Human Services · Phase II · Three-dimensional testicular cell co-culture model for reproductive toxicity screening | $729,931 | |
| Federal grant | Department of Health and Human Services · Phase II · Three-dimensional testicular cell co-culture model for reproductive toxicity screening | $729,931 | |
| Federal grant | Department of Health and Human Services · Phase I · Establishment of human mini-Testis for reproductive toxicity testing | $225,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1567 | AUXAGEN, INC. | — | — |
| 1568 | COGNITION THERAPEUTICS, INC. | — | $23M |
| 1569 | ASYSTBIO LABORATORIES, LLC | — | — |
| 1570 | REPROTOX BIOTECH, LLC | — | — |
| 1571 | Macromoltek | — | — |
| 1572 | Coultreon Biopharma | — | — |
| 1573 | NANORED LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.